ESR1 and breast carcinoma: Though our findings support a harmful effect of LAN in both the ER + and ER − breast cancer subtypes, at high exposure levels i.e., above 30 nW/cm2/sr the curve flattened in women with ER + disease but still increased in the ER − subgroup.